Author Correction: Personalized aerosolised bacteriophage treatment of a chronic lung infection due to multidrug-resistant Pseudomonas aeruginosa

Nat Commun. 2023 Jul 24;14(1):4443. doi: 10.1038/s41467-023-40202-3.

Thilo Köhler^{1

2}, Alexandre Luscher^{3

4}, Léna Falconnet^{3

4}, Grégory Resch⁵, Robert McBride⁶, Quynh-Anh Mai⁶, Juliette L Simonin⁷, Marc Chanson⁷, Bohumil Maco⁴, Raphaël Galiotto⁴, Arnaud Riat⁸, Natacha Civic⁹, Mylène Docquier⁹, Shawna McCallin¹⁰, Benjamin Chan¹¹, Christian van Delden^{3

4}

¹ Service of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland. thilo.kohler@unige.ch.
² Department of Microbiology and Molecular Medicine, University of Geneva, Geneva, Switzerland. thilo.kohler@unige.ch.
³ Service of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.
⁴ Department of Microbiology and Molecular Medicine, University of Geneva, Geneva, Switzerland.
⁵ Center for Research and Innovation in Clinical Pharmaceutical Sciences (CRISP), Lausanne University Hospital (CHUV), Lausanne, Switzerland.
⁶ Felix Biotechnology, San Francisco, CA, USA.
⁷ Department of Cell Physiology and Metabolism, University of Geneva, Geneva, Switzerland.
⁸ Diagnostic Bacteriology Laboratory, Geneva University Hospitals, Geneva, Switzerland.
⁹ iGE3 Genomics Platform, University of Geneva, Geneva, Switzerland.
¹⁰ Department of Neuro-Urology Balgrist Hospital, Zurich, Switzerland.
¹¹ Yale University, New Haven, CT, USA.

No abstract available

Publication types